2019
DOI: 10.37358/rc.19.4.7130
|View full text |Cite
|
Sign up to set email alerts
|

Impact of Therapy with L-Thyroxine on the Evolution of Arterial and Aortic Stiffness in Female Patients with Overt and Subclinical Hypothyroidism

Abstract: The objective of this study is to highlight the impact of therapy with L-thyroxine on the altered arterial stiffness (AS) and reduced aortic distensibility (AoD), as well as on the left ventricular (LV) hypertrophy (LVH) and diastolic dysfunction (DD) in hypothyroid female patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
8
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 16 publications
(32 reference statements)
0
8
0
Order By: Relevance
“…In recent years, studies have also been published regarding the detection rate of cardiac abnormalities using indirect markers, tricuspid regurgitation and inverted wave at the level of the venous duct, these having a reported prediction rate of 32.9% and 28.2% respectively, with a false positive rate of 1.3% and 2.1% [23][24][25][26][27][28].…”
Section:  Discussionmentioning
confidence: 99%
“…In recent years, studies have also been published regarding the detection rate of cardiac abnormalities using indirect markers, tricuspid regurgitation and inverted wave at the level of the venous duct, these having a reported prediction rate of 32.9% and 28.2% respectively, with a false positive rate of 1.3% and 2.1% [23][24][25][26][27][28].…”
Section:  Discussionmentioning
confidence: 99%
“…One of the first theories assumed that PH is the result of the chronically increased blood flow through the arterio-venous fistulas (AVF), used as an access for HD, but several other vasoconstrictive and vasoproliferative processes play an important role. These contributing mechanisms are: vasoconstriction of the pulmonary vasculature due to an imbalance between vasodilator/vasoconstrictor mediators [8], as well as vascular calcifications with thickening of pulmonary arteries, induced by secondary hyperparathyroidism (SHPTH) with alterations in calcium (Ca) and phosphate (P) metabolism [9,10]. Thereby, the occurrence of PH in patients with ESRD undergoing HD, assumes alterations of the pulmonary microvasculature induced by uremic conditions leading to an increased precapillary pulmonary vascular resistance (PVR), followed by the development of PH [11].…”
mentioning
confidence: 99%
“…Hantsoo et al discussed over the evolution of endothelial dysfunction in women with MDD and treated with SSRI [24]. On the other hand, in his study, Scuteri et al debated upon differences between the action of different antidepressants, duloxetine determining even the augmentation of PWV in elderly, comparing to escitalopram who had a neutral effect [25][26][27][28][29][30][31][32].…”
Section: Resultsmentioning
confidence: 99%